EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Risk of Melanoma in Patients with Basal Cell Carcinoma: A Population-based Cohort Study

Daniella Kushnir-Grinbaum, Judit Krausz, Nader Rahal, Liat Apel-Sarid, Michael Ziv

Acta Dermato-Venereologica · 2023

DOI: 10.2340/actadv.v103.4402 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Acta Dermato-Venereologica, 2023. Verfasst von Daniella Kushnir-Grinbaum und 4 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, Emek Medical Center, Yitshak Rabin Boulevard 21, Afula 1834111, Israel. daniellakushnir@gmail.com. Hauptthemen laut MEDLINE: Skin Neoplasms, Basal Cell Carcinoma, Melanoma. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Basal cell carcinoma is the most prevalent cancer in Caucasians worldwide. The aim of this study was to examine the overall risk of melanoma among patients diagnosed with basal cell carcinoma. This population-based retrospective cohort study included data from January 2010 to December 2018 from the databases of the Clalit Health Maintenance Organization and 2 major pathology laboratories in North District, Israel. The incidence and hazard ratio of melanoma in patients with a diagnosis of basal cell carcinoma were determined. Of 466,700 participants, 51% were women and the mean (standard deviation) follow-up was 6.7 (2.9; range 1–9) years. A total of 3,338 patients were diagnosed with basal cell carcinoma during the study period, 82 of whom subsequently developed melanoma. Patients with basal cell carcinoma had a significantly higher incidence of melanoma than patients without basal cell carcinoma (2.46% vs 0.37%; p < 0.0001). Univariate Cox regression analysis revealed a hazard ratio of 6.6 (95% confidence interval: 3.6–12.1; p < 0.0001) for melanoma in patients with a diagnosis of basal cell carcinoma. In conclusion, a diagnosis of basal cell carcinoma confers a significant risk of melanoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsBasal Cell CarcinomaMelanomaHumansFemaleMaleRetrospective StudiesCohort StudiesIncidenceRisk Factors

Autor:innen und Institutionen

  • Dermatology Department, Emek Medical Center, Yitshak Rabin Boulevard 21, Afula 1834111, Israel. daniellakushnir@gmail.com.
  • Pathology Department, Emek Medical Center, Afula, Israel.
  • Dermatology Department, Emek Medical Center, Yitshak Rabin Boulevard 21, Afula 1834111, Israel; Clalit Health Maintenance Service North District, Israel.
  • Patho-Lab Diagnostics, Assuta Medical Centers, Israel.
  • Dermatology Department, Emek Medical Center, Yitshak Rabin Boulevard 21, Afula 1834111, Israel.

Zitieren

APA

Kushnir-Grinbaum, D., Krausz, J., Rahal, N., Apel-Sarid, L., & Ziv, M. (2023). Risk of Melanoma in Patients with Basal Cell Carcinoma: A Population-based Cohort Study. Acta Dermato-Venereologica. https://doi.org/10.2340/actadv.v103.4402

Vancouver

Kushnir-Grinbaum D, Krausz J, Rahal N, Apel-Sarid L, Ziv M. Risk of Melanoma in Patients with Basal Cell Carcinoma: A Population-based Cohort Study. Acta Dermato-Venereologica. 2023. doi:10.2340/actadv.v103.4402

BibTeX
@article{KushnirGrinbaum2023,
  author = {Kushnir-Grinbaum, Daniella and Krausz, Judit and Rahal, Nader and Apel-Sarid, Liat and Ziv, Michael},
  title = {Risk of Melanoma in Patients with Basal Cell Carcinoma: A Population-based Cohort Study},
  journal = {Acta Dermato-Venereologica},
  year = {2023},
  doi = {10.2340/actadv.v103.4402}
}
Kostenlos starten →